Chemoinformaics analysis of quercetin-7-o-rhamnoside
| Molecular Weight | 311.337 | nRot | 1 |
| Heavy Atom Molecular Weight | 294.201 | nRig | 24 |
| Exact Molecular Weight | 311.116 | nRing | 5 |
| Solubility: LogS | -2.135 | nHRing | 2 |
| Solubility: LogP | 2.071 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 40 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 23 | No. of Aromatic Carbocycles | 2 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 17 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 18 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 5 | APOL | 45.7035 |
| nHD | 2 | BPOL | 22.8325 |
| QED | 0.847 |
| Synth | 3.373 |
| Natural Product Likeliness | 2.232 |
| NR-PPAR-gamma | 0.021 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.005 |
| Pgp-sub | 0.697 |
| HIA | 0.002 |
| CACO-2 | -5.044 |
| MDCK | 0.0000157 |
| BBB | 0.854 |
| PPB | 0.869089 |
| VDSS | 1.656 |
| FU | 0.0850589 |
| CYP1A2-inh | 0.789 |
| CYP1A2-sub | 0.486 |
| CYP2c19-inh | 0.312 |
| CYP2c19-sub | 0.686 |
| CYP2c9-inh | 0.012 |
| CYP2c9-sub | 0.579 |
| CYP2d6-inh | 0.658 |
| CYP2d6-sub | 0.908 |
| CYP3a4-inh | 0.321 |
| CYP3a4-sub | 0.772 |
| CL | 11.852 |
| T12 | 0.185 |
| hERG | 0.674 |
| Ames | 0.818 |
| ROA | 0.706 |
| SkinSen | 0.427 |
| Carcinogencity | 0.414 |
| EI | 0.009 |
| Respiratory | 0.854 |
| NR-Aromatase | 0.09 |
| Antiviral | Yes |
| Prediction | 0.790778 |